CA2664133C - A method for correcting a spectral image for optical aberrations using software - Google Patents
A method for correcting a spectral image for optical aberrations using software Download PDFInfo
- Publication number
- CA2664133C CA2664133C CA2664133A CA2664133A CA2664133C CA 2664133 C CA2664133 C CA 2664133C CA 2664133 A CA2664133 A CA 2664133A CA 2664133 A CA2664133 A CA 2664133A CA 2664133 C CA2664133 C CA 2664133C
- Authority
- CA
- Canada
- Prior art keywords
- light
- spectral image
- intensity
- wavelength
- correcting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003595 spectral effect Effects 0.000 title claims abstract description 150
- 230000004075 alteration Effects 0.000 title claims abstract description 85
- 230000003287 optical effect Effects 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims description 306
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 80
- 239000012491 analyte Substances 0.000 claims abstract description 48
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 8
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 238000012937 correction Methods 0.000 abstract description 6
- 238000001228 spectrum Methods 0.000 description 40
- 238000003745 diagnosis Methods 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000004973 liquid crystal related substance Substances 0.000 description 5
- 229910052754 neon Inorganic materials 0.000 description 4
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 4
- 230000001594 aberrant effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 241000226585 Antennaria plantaginifolia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000001237 Raman spectrum Methods 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000003702 image correction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14556—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases by fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
- G01N2021/6423—Spectral mapping, video display
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Spectrometry And Color Measurement (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83916606P | 2006-08-22 | 2006-08-22 | |
| US60/839,166 | 2006-08-22 | ||
| PCT/US2007/018234 WO2008024276A2 (en) | 2006-08-22 | 2007-08-17 | A method for correcting a spectral image for optical aberrations using software |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2664133A1 CA2664133A1 (en) | 2008-02-28 |
| CA2664133C true CA2664133C (en) | 2012-10-23 |
Family
ID=39047978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2664133A Expired - Fee Related CA2664133C (en) | 2006-08-22 | 2007-08-17 | A method for correcting a spectral image for optical aberrations using software |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7705980B2 (enExample) |
| EP (1) | EP2077748A2 (enExample) |
| JP (2) | JP5199256B2 (enExample) |
| CA (1) | CA2664133C (enExample) |
| TW (1) | TW200817666A (enExample) |
| WO (1) | WO2008024276A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
| US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
| WO2005119524A2 (en) | 2004-06-04 | 2005-12-15 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
| US8452365B2 (en) * | 2005-05-25 | 2013-05-28 | Bayer Healthcare Llc | Methods of using Raman spectral information in determining analyte concentrations |
| JP5199256B2 (ja) * | 2006-08-22 | 2013-05-15 | バイエル・ヘルスケア・エルエルシー | ソフトウェアを使用して光学的異常に関してスペクトル画像を補正する方法 |
| WO2009137740A1 (en) * | 2008-05-09 | 2009-11-12 | Hugh Beckman | Medical device for diagnosing and treating anomalous tissue and method for doing the same |
| US9202140B2 (en) * | 2008-09-05 | 2015-12-01 | Siemens Medical Solutions Usa, Inc. | Quotient appearance manifold mapping for image classification |
| JP5424108B2 (ja) * | 2008-11-18 | 2014-02-26 | 株式会社エス・テイ・ジャパン | ラマンイメージング装置 |
| WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
| GB201000179D0 (en) | 2010-01-07 | 2010-02-24 | Rsp Systems As | Apparatus for non-invasive in vivo measurement by raman spectroscopy |
| JP2012122851A (ja) * | 2010-12-08 | 2012-06-28 | St Japan Inc | ラマン分析装置 |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US8891073B2 (en) * | 2011-07-14 | 2014-11-18 | Battelle Energy Alliance, Llc | Apparatus, system, and method for laser-induced breakdown spectroscopy |
| US8861900B2 (en) | 2012-02-23 | 2014-10-14 | Corning Incorporated | Probe optical assemblies and probes for optical coherence tomography |
| US8857220B2 (en) | 2012-02-23 | 2014-10-14 | Corning Incorporated | Methods of making a stub lens element and assemblies using same for optical coherence tomography applications |
| US8967885B2 (en) | 2012-02-23 | 2015-03-03 | Corning Incorporated | Stub lens assemblies for use in optical coherence tomography systems |
| US9036966B2 (en) | 2012-03-28 | 2015-05-19 | Corning Incorporated | Monolithic beam-shaping optical systems and methods for an OCT probe |
| JP6488501B2 (ja) * | 2013-09-11 | 2019-03-27 | 株式会社分光科学研究所 | 計測方法及び計測装置 |
| JP6316064B2 (ja) * | 2014-03-31 | 2018-04-25 | 株式会社日立ハイテクサイエンス | Ｉｃｐ発光分光分析装置 |
| WO2015174819A2 (en) * | 2014-05-16 | 2015-11-19 | Mimos Berhad | Method for producing narrow spectral linewidths |
| FR3035716B1 (fr) * | 2015-04-30 | 2019-06-21 | Biomerieux | Machine et procede pour la detection automatisee in vitro d'analytes mettant en oeuvre une decomposition spectrale chromatique d'une reponse optique |
| DE102018205400A1 (de) | 2018-04-10 | 2019-10-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Spektralanalysesystem, mobiles gerät mit einem spektralanalysesystem, ein verfahren zur bestimmung einer korrekturfunktion zur abbildungskorrektur eines durch ein spektralanalysesystem aufgenommenen spektrums und computerprogramm |
| KR102655740B1 (ko) * | 2018-06-20 | 2024-04-05 | 삼성전자주식회사 | 스펙트럼 이미지 보정 장치 및 방법과, 대상체의 성분 분석 장치 |
| US11740128B2 (en) * | 2019-07-24 | 2023-08-29 | Sanguis Corporation | System and method for non-invasive measurement of analytes in vivo |
| CN114910416B (zh) * | 2022-04-28 | 2024-07-30 | 彩谱科技(浙江)有限公司 | 一种高光谱颜色测量定标系统及定标方法 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4645340A (en) * | 1983-06-01 | 1987-02-24 | Boston University | Optically reflective sphere for efficient collection of Raman scattered light |
| GB2141554A (en) * | 1983-06-15 | 1984-12-19 | Philips Electronic Associated | A slit imaging system using two concave mirrors |
| DE69231614T2 (de) * | 1991-02-26 | 2001-05-03 | Massachusetts Institute Of Technology, Cambridge | Molekularspektroskopieverfahren und -einrichtungen zur gewebediagnose |
| US5404869A (en) | 1992-04-16 | 1995-04-11 | Tir Technologies, Inc. | Faceted totally internally reflecting lens with individually curved faces on facets |
| US5560356A (en) * | 1994-02-23 | 1996-10-01 | Vitrophage, Inc. | Diagnostic system and method using an implanted reflective device |
| US5615673A (en) * | 1995-03-27 | 1997-04-01 | Massachusetts Institute Of Technology | Apparatus and methods of raman spectroscopy for analysis of blood gases and analytes |
| JP3792273B2 (ja) * | 1995-06-30 | 2006-07-05 | 株式会社島津製作所 | 分光測定装置 |
| JPH09184809A (ja) * | 1995-12-30 | 1997-07-15 | Koyo Ozaki | 散乱光測定装置 |
| US5923482A (en) * | 1997-03-14 | 1999-07-13 | Waters Investments Limited | Changing astigmatism in an optical system |
| ATE352252T1 (de) * | 1997-11-12 | 2007-02-15 | Lightouch Medical Inc | Verfahren zur nicht invasiven analytenmessung |
| US6070093A (en) * | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
| US6051835A (en) * | 1998-01-07 | 2000-04-18 | Bio-Rad Laboratories, Inc. | Spectral imaging apparatus and methodology |
| JP2002500908A (ja) * | 1998-01-27 | 2002-01-15 | ライタッチ メディカル インコーポレイテッド | 組織変調装置およびその方法 |
| US6560478B1 (en) * | 1998-03-16 | 2003-05-06 | The Research Foundation Of City University Of New York | Method and system for examining biological materials using low power CW excitation Raman spectroscopy |
| DE69918285T2 (de) * | 1998-04-24 | 2005-08-18 | Lightouch Medical, Inc. | Gerät und verfahren zur thermischen modulation von gewebe |
| US6389306B1 (en) * | 1998-04-24 | 2002-05-14 | Lightouch Medical, Inc. | Method for determining lipid and protein content of tissue |
| DE69903306T2 (de) * | 1998-07-07 | 2003-05-22 | Lightouch Medical, Inc. | Verfahren zur gewebemodulation für die quantitative nichtinvasive in vivo spektroskopische analyse von gewebe |
| US6332092B1 (en) * | 1998-07-08 | 2001-12-18 | Lifespex, Incorporated | Optical probe having and methods for uniform light irradiation and/or light collection over a volume |
| US6615061B1 (en) * | 1998-11-23 | 2003-09-02 | Abbott Laboratories | Optical sensor having a selectable sampling distance for determination of analytes |
| US6352502B1 (en) * | 1998-12-03 | 2002-03-05 | Lightouch Medical, Inc. | Methods for obtaining enhanced spectroscopic information from living tissue, noninvasive assessment of skin condition and detection of skin abnormalities |
| US6503478B2 (en) * | 1999-01-13 | 2003-01-07 | Lightouch Medical, Inc. | Chemically specific imaging of tissue |
| US6167290A (en) * | 1999-02-03 | 2000-12-26 | Bayspec, Inc. | Method and apparatus of non-invasive measurement of human/animal blood glucose and other metabolites |
| US6486948B1 (en) * | 1999-09-14 | 2002-11-26 | Haishan Zeng | Apparatus and methods relating to high speed Raman spectroscopy |
| US6574490B2 (en) * | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
| US6983176B2 (en) * | 2001-04-11 | 2006-01-03 | Rio Grande Medical Technologies, Inc. | Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
| US6561648B2 (en) * | 2001-05-23 | 2003-05-13 | David E. Thomas | System and method for reconstruction of aberrated wavefronts |
| JP4494779B2 (ja) * | 2001-08-02 | 2010-06-30 | グルコビスタ・エルエルシー | 非侵襲グルコース計測器 |
| AU2002324605A1 (en) * | 2001-08-03 | 2003-02-17 | Joseph A Izatt | Real-time imaging system and method |
| US6636305B2 (en) | 2001-09-13 | 2003-10-21 | New Chromex, Inc. | Apparatus and method for producing a substantially straight instrument image |
| US7226166B2 (en) * | 2001-11-13 | 2007-06-05 | Philadelphia Retina Endowment Fund | Optimizing the properties of electromagnetic energy in a medium using stochastic parallel perturbation gradient descent optimization adaptive optics |
| US6975891B2 (en) * | 2001-12-21 | 2005-12-13 | Nir Diagnostics Inc. | Raman spectroscopic system with integrating cavity |
| AU2003264797A1 (en) | 2002-09-05 | 2004-03-29 | Pendragon Medical Ltd. | Impedance spectroscopy based systems and methods |
| WO2004064627A1 (en) | 2003-01-21 | 2004-08-05 | British Columbia Cancer Agency | In vivo raman endoscopic probe and methods of use |
| JP2006520638A (ja) * | 2003-03-18 | 2006-09-14 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 監視による構成要素の分析 |
| US20050043597A1 (en) * | 2003-07-31 | 2005-02-24 | Skymoon Research And Development, Llc | Optical vivo probe of analyte concentration within the sterile matrix under the human nail |
| US7046359B2 (en) * | 2004-06-30 | 2006-05-16 | Chemimage Corporation | System and method for dynamic chemical imaging |
| JP4512465B2 (ja) * | 2004-10-13 | 2010-07-28 | 株式会社日立ハイテクノロジーズ | 電気泳動装置 |
| US8452365B2 (en) | 2005-05-25 | 2013-05-28 | Bayer Healthcare Llc | Methods of using Raman spectral information in determining analyte concentrations |
| EP1931969A1 (en) * | 2005-09-16 | 2008-06-18 | The Regents of the University of Michigan | Method and system for measuring sub-surface composition of a sample |
| JP5199256B2 (ja) * | 2006-08-22 | 2013-05-15 | バイエル・ヘルスケア・エルエルシー | ソフトウェアを使用して光学的異常に関してスペクトル画像を補正する方法 |
| US7603151B2 (en) * | 2006-08-22 | 2009-10-13 | Bayer Healthcare Llc | Non-invasive methods of using spectral information in determining analyte concentrations |
-
2007
- 2007-08-17 JP JP2009525569A patent/JP5199256B2/ja not_active Expired - Fee Related
- 2007-08-17 EP EP07811384A patent/EP2077748A2/en not_active Withdrawn
- 2007-08-17 CA CA2664133A patent/CA2664133C/en not_active Expired - Fee Related
- 2007-08-17 WO PCT/US2007/018234 patent/WO2008024276A2/en not_active Ceased
- 2007-08-21 US US11/894,511 patent/US7705980B2/en not_active Expired - Fee Related
- 2007-08-22 TW TW096131101A patent/TW200817666A/zh unknown
-
2010
- 2010-03-11 US US12/722,043 patent/US7944556B2/en not_active Expired - Fee Related
-
2013
- 2013-01-24 JP JP2013011079A patent/JP2013101142A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2664133A1 (en) | 2008-02-28 |
| US7705980B2 (en) | 2010-04-27 |
| TW200817666A (en) | 2008-04-16 |
| JP2010501251A (ja) | 2010-01-21 |
| WO2008024276A3 (en) | 2008-05-08 |
| US20100226549A1 (en) | 2010-09-09 |
| WO2008024276A2 (en) | 2008-02-28 |
| EP2077748A2 (en) | 2009-07-15 |
| US7944556B2 (en) | 2011-05-17 |
| US20080059100A1 (en) | 2008-03-06 |
| JP5199256B2 (ja) | 2013-05-15 |
| JP2013101142A (ja) | 2013-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2664133C (en) | A method for correcting a spectral image for optical aberrations using software | |
| JP6531044B2 (ja) | 診断装置及び方法 | |
| US7808634B2 (en) | Method and apparatus for automated spectral calibration | |
| Lasch | Spectral pre-processing for biomedical vibrational spectroscopy and microspectroscopic imaging | |
| US6276798B1 (en) | Spectral bio-imaging of the eye | |
| US6198532B1 (en) | Spectral bio-imaging of the eye | |
| CA2445044C (en) | Method and apparatus for correcting crosstalk and spatial resolution for multichannel imaging | |
| Krafft et al. | Raman and infrared spectroscopic mapping of human primary intracranial tumors: a comparative study | |
| US20120310538A1 (en) | System and Method for Diagnosing a Biological Sample | |
| CN101023331A (zh) | 生物细胞和其它对象的动态化学成像 | |
| CN105324064A (zh) | 生成示出生物组织中生物物质浓度分布图像的方法和装置 | |
| JP2008545974A (ja) | オーバーラップした画像を用いる光学分光法 | |
| WO2000067635A1 (en) | Spectral bio-imaging of the eye | |
| US20070182959A1 (en) | Dynamic imaging of biological cells and other subjects | |
| JP2008309707A (ja) | 分光計測装置及び分光計測方法 | |
| Martín-Pérez et al. | Spectral analysis comparison of pushbroom and snapshot hyperspectral cameras for in vivo brain tissues and chromophore identification | |
| Waterhouse et al. | Quantitative evaluation of comb-structure correction methods for multispectral fibrescopic imaging | |
| Shih et al. | Noninvasive glucose sensing with Raman spectroscopy | |
| JP3474883B2 (ja) | 可動物の、干渉形に基づくスペクトル結像装置 | |
| Kester et al. | Real-time hyperspectral endoscope for early cancer diagnostics | |
| US7239383B2 (en) | Method and apparatus for spectral modulation compensation | |
| Pawluczyk et al. | Applications of multichannel imaging spectrometer | |
| Guenot et al. | A novel concept of compact, snapshot hyperspectral camera for ophthalmology. | |
| JP2001153795A (ja) | 光生体測定装置 | |
| Shih et al. | Quantitative biological Raman spectroscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150817 |
|
| MKLA | Lapsed |
Effective date: 20150817 |